(Q37825925)

23 August 2017

1 reference

title

The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes (English)

1 reference

23 August 2017

3

1 reference

23 August 2017

E B de Oliveira-Junior

series ordinal

1

1 reference

PubMed ID

21204900

23 August 2017

J Bustamante

series ordinal

2

1 reference

PubMed ID

21204900

23 August 2017

A Condino-Neto

series ordinal

4

1 reference

23 August 2017

1 May 2011

1 reference

Scandinavian Journal of Immunology

23 August 2017

1 reference

23 August 2017

73

1 reference

23 August 2017

5

1 reference

23 August 2017

420-427

1 reference

Biological roles for the NOX family NADPH oxidases

23 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Cloning the gene for the inherited disorder chronic granulomatous disease on the basis of its chromosomal location.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Oxidative killing of microbes by neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

A Fatal Granulomatous Disease of Childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Hematologically important mutations: X-linked chronic granulomatous disease (third update)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Chronic granulomatous disease. Report on a national registry of 368 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Chronic granulomatous disease in Latin American patients: clinical spectrum and molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Clinical aspects of chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Long-term interferon-gamma therapy for patients with chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Restoration of NET formation by gene therapy in CGD controls aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Advances in the treatment of Chronic Granulomatous Disease by gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Efficacy of gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Killing of pathogens associated with chronic granulomatous disease by the non-oxidative microbicidal mechanisms of human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Killing activity of neutrophils is mediated through activation of proteases by K+ flux

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

DNA linkage analysis of X chromosome-linked chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

HoxA10 represses transcription of the gene encoding p67phox in phagocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Regulation of the myeloid-cell-expressed human gp91-phox gene as studied by transfer of yeast artificial chromosome clones into embryonic stem cells: suppression of a variegated cellular pattern of expression requires a full complement of distant ci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Mutational analysis of patients with p47-phox-deficient chronic granulomatous disease: The significance of recombination events between the p47-phox gene (NCF1) and its highly homologous pseudogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

A novel mutation in NCF1 in an adult CGD patient with a liver abscess as first presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47 degrees chronic granulomatous disease carrier detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

The superoxide-generating NADPH oxidase: structural aspects and activation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Genetics and immunopathology of chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Circuitry of nuclear factor kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

IkappaB kinase-dependent chronic activation of NF-kappaB is necessary for p21(WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

21 January 2018

The NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Essential role of nuclear factor-kappaB for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Inherited disorders of NF-kappaB-mediated immunity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Pyogenic bacterial infections in humans with IRAK-4 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Cross-talk between IRAK-4 and the NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Association of glucose-6-phosphate dehydrogenase deficiency and X-linked chronic granulomatous disease in a child with anemia and recurrent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

Shigella sonnei Meningitis Due to Interleukin-1 Receptor--Associated Kinase--4 Deficiency: First Association with a Primary Immune Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2010.02501.X

10.1111/J.1365-3083.2010.02501.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21204900